According to the implant registration card (irc) a patient implanted with an on-x mitral heart valve and conform-x sewing ring (onxmc-25/33, sn (b)(4)) on (b)(6) 2015 which was explanted on (b)(6) 2016 and replaced with another onxmc-25/33.Attempts to obtain additional clarifying information were unsuccessful.A phone call was made to the hospital on 10/12/2016 without success in obtaining information but on 10/13/2016 it was indicated by staff that no information would be released for the patient.The manufacturing records for the onxmc-25/33, sn (b)(4), were reviewed and it was confirmed that all records were controlled, available for review, and met all specifications per the device master record.All lots passed functional testing and met release specifications.During the investigation no non-conformances or deviations were noted.The onxmc-25/33, sn (b)(4), was implanted (b)(6) 2015 in the mitral position via mvr and required explant (28 post-op) on (b)(6) 2016 and replacement by another onxmc-25/33.There is insufficient information available to ascertain what, if any, relationship the explantation had to the valve.Reoperation and explantation are known risks of prosthetic heart valves of any brand and are not unique to the on-x valve.Both events are listed in the potential adverse events section found in the onxmc instructions for use (ifu).
|